Picture of Nanexa AB logo

NANEXA Nanexa AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Brief: Nanexa Says Approval Of Clinical Trial Application For Nex-22 Study Delayed

April 16 (Reuters) - Nanexa AB  NANEXA.ST :
    * APPROVAL OF CLINICAL TRIAL APPLICATION FOR NEX-22 STUDY
DELAYED

Source text for Eikon:  ID:nMFN9qMpDq 
Further company coverage:  NANEXA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Nanexa AB

See all news